Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Liver Diseases

Free Subscription Articles published in Dig Dis Sci Retrieve available abstracts of 260 articles: HTML format

Single Articles

April 2026
1. LING J, Qian B
   Imaging-Pathology Correlation of Classic Hepatic Focal Nodular Hyperplasia: The Central Stellate Scar.
   Dig Dis Sci. 2026 Apr 25. doi: 10.1007/s10620-026-09940.
   PubMed    
   
   
   
2. HUA L, Fu J, Gu X, Zhou S, et al
   Single-Cell Transcriptomics Dissects the Molecular Mechanism by Which Macrophage Polarization Drives Hepatocellular Carcinoma Metastasis Through Crosstalk with Emt-Tumor Microenvironment.
   Dig Dis Sci. 2026 Apr 25. doi: 10.1007/s10620-026-09921.
   PubMed     Abstract available
   
   
   
3. RAMJI HF, Gatiganti A, Janwadkar A, Lampenfeld J, et al
   The Impact of Specific Prompt Engineering Techniques on the Readability of LLM-Generated Patient Materials in Gastroenterology and Hepatology.
   Dig Dis Sci. 2026 Apr 9. doi: 10.1007/s10620-026-09879.
   PubMed     Abstract available
   
   
   
4. LIM RY, Low PJS, Lim WH, Selvakumar A, et al
   Impact of Transjugular Intrahepatic Portosystemic Shunt on Waitlist and Post-transplant Outcomes in Liver Transplant Candidates.
   Dig Dis Sci. 2026 Apr 4. doi: 10.1007/s10620-026-09825.
   PubMed     Abstract available
   
   
   
5. FAR AT, Ayati A, Guillot J, Azzam S, et al
   Large Language Models can Identify the Presence of MASH and Extract VCTE Measurements from Unstructured Documentation.
   Dig Dis Sci. 2026;71:1505-1511.
   PubMed     Abstract available
   
   
   
6. CHAN SY, Yeo YH, Kim H, Delk M, et al
   Trends in Concurrent Psychiatric Comorbidities in Alcohol-Associated Liver Disease: A Nationwide Study from 2015-2023.
   Dig Dis Sci. 2026;71:1493-1504.
   PubMed     Abstract available
   
   
   March 2026
7. SPANN A, Louissaint J
   Advancing Advance Directive Completion Rates in Patients with Decompensated Cirrhosis.
   Dig Dis Sci. 2026 Mar 11. doi: 10.1007/s10620-026-09815.
   PubMed    
   
   
   
8. TANG S, Chen H
   Regulatory Role of Ribosome Biogenesis-Related Genes in Hepatocellular Carcinoma Prognosis and Construction of a Risk Prediction Model.
   Dig Dis Sci. 2026 Mar 3. doi: 10.1007/s10620-026-09787.
   PubMed     Abstract available
   
   
   
9. RANGWANI S, Ying X, Jesudian AB
   From Hepatic Encephalopathy to Physiologic Reserve: Rifaximin's Second Act in Cirrhosis.
   Dig Dis Sci. 2026 Mar 2. doi: 10.1007/s10620-026-09790.
   PubMed    
   
   
   
10. ZHANG W, Hu H
    The Emerging Therapeutic Promise of SGLT2 Inhibitors in Metabolic Dysfunction-Associated Steatotic Liver Disease.
    Dig Dis Sci. 2026;71:852-867.
    PubMed     Abstract available
    
    
    
11. MEGURO J, Huber M, Goldberg D
    State-Level Variability in Location of Death of Patients with End-Stage Liver Disease.
    Dig Dis Sci. 2026;71:933-940.
    PubMed     Abstract available
    
    
    
12. BHARADWAJ HR, Dahiya DS, Dalal P, Fuad M, et al
    Inequalities in Gastrointestinal Care Provision in the United Kingdom.
    Dig Dis Sci. 2026;71:822-837.
    PubMed     Abstract available
    
    
    February 2026
13. LEE SY, Lim CW, Kim S, Majeed UBA, et al
    Using the EVendo Score to Predict Varices and Varices Needing Treatment in Hepatocellular Carcinoma Patients Planned for Atezolizumab-Bevacizumab.
    Dig Dis Sci. 2026 Feb 26. doi: 10.1007/s10620-026-09776.
    PubMed     Abstract available
    
    
    
14. LIU JH, Yang JL, Wang R
    Cholangioscopy Combined with Percutaneous Transhepatic Cholangial Drainage Methylene Blue Injection Facilitating Dominant Intrahepatic Duct Stent Placement.
    Dig Dis Sci. 2026 Feb 11. doi: 10.1007/s10620-026-09738.
    PubMed    
    
    
    
15. LIU Z, Zhang M, Liu C, Zhang H, et al
    Near-Focus Mode Facilitating Underwater ESD for Laterally Spreading Tumor in the Hepatic Flexure of the Colon.
    Dig Dis Sci. 2026 Feb 11. doi: 10.1007/s10620-026-09732.
    PubMed    
    
    
    
16. JIANG Z, Zhang J, Zhang X, Xie C, et al
    Comment on "Agile 3 + and 4 Scores Accurately Predict Major Adverse Liver Outcomes, Liver Transplant, Progression of MELD Score, the Development of Hepatocellular Carcinoma, and Death in NAFLD".
    Dig Dis Sci. 2026 Feb 4. doi: 10.1007/s10620-026-09726.
    PubMed    
    
    
    
17. MIRONOVA M, Zaiman Z, Samuel MC, Gichoya JW, et al
    Real World Performance of the Model for End-Stage Liver Disease Score Across Different Races and Ethnicities.
    Dig Dis Sci. 2026;71:643-650.
    PubMed     Abstract available
    
    
    January 2026
18. ROSE S, Ashraf MU, Shastri A, Priya K, et al
    Rifaximin Improves Frailty in Patients with Decompensated Cirrhosis: A Randomized Trial.
    Dig Dis Sci. 2026 Jan 24. doi: 10.1007/s10620-025-09660.
    PubMed     Abstract available
    
    
    
19. TSUJI Y, Namisaki T, Yoshjji H
    Response to the Letter to the Editor Regarding "Risk Factors for Intrahepatic Distant Recurrence After Radiofrequency Ablation for Hepatocellular Carcinoma".
    Dig Dis Sci. 2026 Jan 23. doi: 10.1007/s10620-025-09642.
    PubMed    
    
    
    
20. WILLIAMS EE, Lammert C, Vuppalanchi R
    Impact of Type 2 Diabetes Mellitus on Liver Fibrosis and Hepatic Steatosis in Patients with Primary Biliary Cholangitis: A Longitudinal Study.
    Dig Dis Sci. 2026 Jan 12. doi: 10.1007/s10620-026-09672.
    PubMed     Abstract available
    
    
    
21. LAI SW, Chiu SC, Liao KF
    Lipid?Lowering Agents and Hepatocellular Carcinoma Risk.
    Dig Dis Sci. 2026 Jan 2. doi: 10.1007/s10620-025-09631.
    PubMed    
    
    
    December 2025
22. PATEL AA, Walling AM, Sudore RL, Tseng CH, et al
    Advance Directive Completion Among Community-Dwelling Adults with Decompensated Cirrhosis.
    Dig Dis Sci. 2025 Dec 27. doi: 10.1007/s10620-025-09616.
    PubMed     Abstract available
    
    
    
23. LIAO L, Li Y, Wei B, Fei M, et al
    CKAP5: Unraveling Its Crucial Function in Liver Hepatocellular Carcinoma Progression and Prognosis.
    Dig Dis Sci. 2025 Dec 23. doi: 10.1007/s10620-025-09632.
    PubMed     Abstract available
    
    
    
24. DODGE JL, Kim B
    Branched-Chain Amino Acid Supplementation in Patients with Cirrhosis: Boon, Bust, or Bull?
    Dig Dis Sci. 2025 Dec 16. doi: 10.1007/s10620-025-09614.
    PubMed    
    
    
    
25. ZHANG J, Ren Y
    Lean MASLD Cirrhosis and Mortality: Considerations for Liver Transplant Candidate Evaluation.
    Dig Dis Sci. 2025 Dec 11. doi: 10.1007/s10620-025-09601.
    PubMed    
    
    
    
26. CHEN X, Wang L, Yan Y, Qin J, et al
    Colorectal Metastasis of Hepatocellular Carcinoma Mimicking Yamada Type III Polyp Leading to Gastrointestinal Bleeding.
    Dig Dis Sci. 2025 Dec 8. doi: 10.1007/s10620-025-09579.
    PubMed    
    
    
    
27. VONGSAVATH T, Manne V, Sakae C, Saab S, et al
    Management of Refractory Hepatic Encephalopathy.
    Dig Dis Sci. 2025 Dec 5. doi: 10.1007/s10620-025-09591.
    PubMed     Abstract available
    
    
    November 2025
28. XUE Q, Peng F, Guo C, Zhou Y, et al
    S100A6 Regulated by PATZ1 Promotes Liver Fibrosis by Activating Hepatic Stellate Cells.
    Dig Dis Sci. 2025 Nov 13. doi: 10.1007/s10620-025-09533.
    PubMed     Abstract available
    
    
    
29. MA AT, Sola E
    Differentiating Hepatorenal Syndrome from Acute Tubular Necrosis in Patients with Decompensated Cirrhosis: Can Metabolomics or Proteomics Help?
    Dig Dis Sci. 2025 Nov 12. doi: 10.1007/s10620-025-09513.
    PubMed    
    
    
    
30. CAO L, Huang Y, Zhao J, Qiu Y, et al
    Dihydroartemisinin: A Targeting Agent of CCT3-Mediated Oxidative Stress to Enhance the Antitumor Activity of Doxorubicin in Hepatocellular Carcinoma.
    Dig Dis Sci. 2025 Nov 8. doi: 10.1007/s10620-025-09503.
    PubMed     Abstract available
    
    
    
31. MA S, Alsabawi Y, Kanwal F, Duong H, et al
    The Association Between Physical Activity, Sedentary Time, and Sleep with Risk of Hepatocellular Carcinoma in Patients with Cirrhosis.
    Dig Dis Sci. 2025 Nov 7. doi: 10.1007/s10620-025-09527.
    PubMed     Abstract available
    
    
    
32. LEE SS, Thornton LM, Jones PD, Goldberg DS, et al
    Investigating Disparities Related to Insurance Status and Access to Locoregional Therapies for Patients with Hepatocellular Carcinoma Awaiting Liver Transplantation.
    Dig Dis Sci. 2025 Nov 1. doi: 10.1007/s10620-025-09462.
    PubMed     Abstract available
    
    
    
33. KUMAR S, Lahooti A, Hajifathalian K, Critelli B, et al
    Prospective, Matched Case-Control Study of Endoscopic Sleeve Gastroplasty and Semaglutide in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease at One Year.
    Dig Dis Sci. 2025;70:3922-3928.
    PubMed     Abstract available
    
    
    October 2025
34. BISWAS S, Mehta S, Swaroop S, Aggarwal A, et al
    Clinical Outcomes of Intravenous Albumin Administration After Acute Variceal Hemorrhage in Patients with Cirrhosis: An Open-Label, Randomized Controlled Trial.
    Dig Dis Sci. 2025 Oct 27. doi: 10.1007/s10620-025-09485.
    PubMed     Abstract available
    
    
    
35. SILVA ML, Prado R
    Systematic Mapping of Worldwide Research on Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction-Associated Steatohepatitis (MASH).
    Dig Dis Sci. 2025 Oct 25. doi: 10.1007/s10620-025-09498.
    PubMed     Abstract available
    
    
    
36. BHARADWAJ HR, Dahiya DS, Dalal P, Fuad M, et al
    Artificial Intelligence in Population-Level Gastroenterology and Hepatology: A Comprehensive Review of Public Health Applications and Quantitative Impact.
    Dig Dis Sci. 2025 Oct 24. doi: 10.1007/s10620-025-09452.
    PubMed     Abstract available
    
    
    
37. BHATI G, Bhati K, Gupta A, Bansal R, et al
    Hitting the Nail on the Head: A Laparoscopic Retrieval of a Metallic Intrahepatic Foreign Body.
    Dig Dis Sci. 2025 Oct 22. doi: 10.1007/s10620-025-09477.
    PubMed     Abstract available
    
    
    
38. ISMAIL A, Abusuliman M, Kloub M, Abbarh S, et al
    Comparative Risk of Recurrent Esophageal Variceal Hemorrhage and Other Decompensation Events with Carvedilol Versus Propranolol in Patients with Cirrhosis: A Retrospective Study.
    Dig Dis Sci. 2025 Oct 18. doi: 10.1007/s10620-025-09453.
    PubMed     Abstract available
    
    
    
39. NASIR AB, Alkhouri N, Gish R, Jain AK, et al
    Advancing the Diagnosis and Management of Genetic Cholestatic Liver Disease in Adults.
    Dig Dis Sci. 2025 Oct 9. doi: 10.1007/s10620-025-09431.
    PubMed     Abstract available
    
    
    
40. TAN Y, Zhang X, Wang J, Xiao X, et al
    EphA3/EFNA3 Reverse Signalling Promotes Epithelial-to-Mesenchymal Transition via ERK Pathway to Facilitate Colorectal Cancer Metastasis.
    Dig Dis Sci. 2025;70:3356-3368.
    PubMed     Abstract available
    
    
    
41. HAIMI M, Baker FA, Vinker S, Safadi R, et al
    Association Between High FIB-4 Score and the Risk of Malignancy Development and Mortality: A Retrospective Longitudinal Case-Control Study.
    Dig Dis Sci. 2025;70:3525-3537.
    PubMed     Abstract available
    
    
    September 2025
42. RODRIGUES SG
    NIT Picking-How the Careful Selection of Non-invasive Tools Has Improved the Diagnosis of Portal Hypertension in Patients with Compensated Advanced Chronic Liver Disease.
    Dig Dis Sci. 2025 Sep 30. doi: 10.1007/s10620-025-09440.
    PubMed    
    
    
    
43. TIE G, Shao S, Shuang J, He Q, et al
    A Rare Anomaly of Cystic Duct Drainage into a Variant Right Hepatic Duct: Cholangioscopy Diagnosis and Management.
    Dig Dis Sci. 2025 Sep 28. doi: 10.1007/s10620-025-09434.
    PubMed    
    
    
    
44. CHEN Y, Feng H, Bao Y, Yan M, et al
    Cost-Effectiveness of Risk-Score-Based Surveillance Strategies for Hepatocellular Carcinoma in Patients with Chronic Hepatitis B.
    Dig Dis Sci. 2025 Sep 27. doi: 10.1007/s10620-025-09419.
    PubMed     Abstract available
    
    
    
45. ACHARYA R, Soundararajan R, Gupta P, Gupta R, et al
    EUS-Guided Diagnosis of Hepatic Tuberculosis Presenting as Postoperative Fistula.
    Dig Dis Sci. 2025 Sep 23. doi: 10.1007/s10620-025-09421.
    PubMed    
    
    
    
46. CULLARO G, Allegretti AS, Patidar KR, Verna EC, et al
    Embracing Imperfect Tools to Decode AKI in Decompensated Cirrhosis.
    Dig Dis Sci. 2025 Sep 7. doi: 10.1007/s10620-025-09379.
    PubMed    
    
    
    
47. NG N, Purkayastha S, Ying X, Jesudian A, et al
    Socioeconomic Factors Impact the Perception of Healthcare Experiences in Patients with Cirrhosis.
    Dig Dis Sci. 2025 Sep 6. doi: 10.1007/s10620-025-09374.
    PubMed     Abstract available
    
    
    
48. NIU J, Wu W, Zhang H, Li Z, et al
    Correction: Aflatoxin B1 Promotes M2-like Macrophage Polarization via IL-6 Expression in Hepatocellular Carcinoma.
    Dig Dis Sci. 2025 Sep 4. doi: 10.1007/s10620-025-09376.
    PubMed    
    
    
    
49. JINDAL A, Singh H, Sharma MK, Vashistha C, et al
    Correlation of Spleen Stiffness with Esophageo-gastric Variceal Bleeding in Patients with Non-cirrhotic Portal Hypertension.
    Dig Dis Sci. 2025 Sep 2. doi: 10.1007/s10620-025-09356.
    PubMed     Abstract available
    
    
    
50. ILAGAN-YING YC
    An AUDacious Proposal: How to Improve Gastroenterology Fellow Training for Alcohol Use Disorder and Alcohol-Associated Liver Disease.
    Dig Dis Sci. 2025;70:2940-2943.
    PubMed     Abstract available
    
    
    August 2025
51. RAO AK, Rockey DC
    Impact of Levothyroxine on Progression to and Complications of Cirrhosis in MASH.
    Dig Dis Sci. 2025 Aug 30. doi: 10.1007/s10620-025-09375.
    PubMed     Abstract available
    
    
    
52. LI K, Wang X, Wang Y, Zhu L, et al
    Exploring Cuproptosis-Related Prognostic Signature for Hepatocellular Carcinoma: Bioinformatics and In Vitro Analyses.
    Dig Dis Sci. 2025 Aug 28. doi: 10.1007/s10620-025-09354.
    PubMed     Abstract available
    
    
    
53. KUMAR A, Raj A, Chaman Lal K, Puja, et al
    Intratumoral Microbe Correlated with Expression of DNA Methylation Genes in Hepatocellular Carcinoma.
    Dig Dis Sci. 2025 Aug 27. doi: 10.1007/s10620-025-09351.
    PubMed    
    
    
    
54. FAIZ M, Usman M, Irshad NUN
    Clinical Insights on "Applying Metabolomics and Aptamer-Based Proteomics to Determine Pathophysiologic Differences in Decompensated Cirrhosis Patients Hospitalized with Acute Kidney Injury".
    Dig Dis Sci. 2025 Aug 19. doi: 10.1007/s10620-025-09329.
    PubMed    
    
    
    
55. ZHANG Q, Liu P, Xu X, Yang Y, et al
    Clinical Outcomes of Acute Pancreatitis in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2025 Aug 14. doi: 10.1007/s10620-025-09300.
    PubMed     Abstract available
    
    
    
56. WEI R, Wang X, Zhao X, Zhang W, et al
    An Unusual Cause of Treatable Portal Hypertension.
    Dig Dis Sci. 2025 Aug 13. doi: 10.1007/s10620-025-09330.
    PubMed    
    
    
    
57. NIU J, Wu W, Zhang H, Li Z, et al
    Aflatoxin B1 Promotes M2-like Macrophage Polarization via IL-6 Expression in Hepatocellular Carcinoma.
    Dig Dis Sci. 2025 Aug 11. doi: 10.1007/s10620-025-09230.
    PubMed     Abstract available
    
    
    
58. ABATE HM, Bujnowski D, Jowell A, Moylan CA, et al
    Ubiquitous Environmental Exposures and Risk of Hepatocellular Carcinoma: A Narrative Review.
    Dig Dis Sci. 2025 Aug 10. doi: 10.1007/s10620-025-09212.
    PubMed     Abstract available
    
    
    
59. TAMBAKI M, Neonaki A, Lekakis V, Papatheodoridi M, et al
    Monitoring Liver and Spleen Stiffness Changes May Predict Clinical Response to Non-selective B-Blockers in Portal Hypertension: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2025 Aug 9. doi: 10.1007/s10620-025-09304.
    PubMed     Abstract available
    
    
    
60. BAKER B, Aridi TG, Patel M, Carter A, et al
    Social Determinants Are Important Barriers to Completion of the Liver Transplant Pathway and Are Associated with Waitlisting and Mortality in Hepatocellular Carcinoma.
    Dig Dis Sci. 2025 Aug 6. doi: 10.1007/s10620-025-09278.
    PubMed     Abstract available
    
    
    
61. ALDIABAT M, Aljabiri Y, Aleyadeh W, Madi MY, et al
    Branched-Chain Amino Acid Supplementation and Clinical Outcomes in Liver Cirrhosis: A Propensity Score-Matched Multicenter Retrospective Cohort Study.
    Dig Dis Sci. 2025 Aug 5. doi: 10.1007/s10620-025-09258.
    PubMed     Abstract available
    
    
    
62. CULLARO G, Allegretti AS, Patidar KR, Verna EC, et al
    Applying Metabolomics and Aptamer-Based Proteomics to Determine Pathophysiologic Differences in Decompensated Cirrhosis Patients Hospitalized with Acute Kidney Injury.
    Dig Dis Sci. 2025 Aug 1. doi: 10.1007/s10620-025-09223.
    PubMed     Abstract available
    
    
    
63. LIU Y, Liu Q, Huang T, Zhang S, et al
    cPDS Promotes Cell Apoptosis by Reducing the Translational Efficiency of BIRC3 mRNA in HCC.
    Dig Dis Sci. 2025;70:2706-2718.
    PubMed     Abstract available
    
    
    July 2025
64. OGURICK AG, Chen K, Sobani Z, Assis DN, et al
    Determining Best Practices and Content for Foundational Ambulatory GI and Hepatology Teaching During GI Fellowship.
    Dig Dis Sci. 2025 Jul 31. doi: 10.1007/s10620-025-09294.
    PubMed     Abstract available
    
    
    
65. MASOOD M, Inamdar S, Thandassery RB
    Opposition Research: Endoscopic Management of Acute Cholecystitis in Patients with Decompensated Cirrhosis.
    Dig Dis Sci. 2025 Jul 29. doi: 10.1007/s10620-025-09272.
    PubMed    
    
    
    
66. HU B, Zhang Y, Jiang B, Li A, et al
    A Bioinformatics Analysis on the Subtypes of Hepatocellular Carcinoma Related to RNA Processing Genes to Reveal Prognosis and Immune Microenvironment Features.
    Dig Dis Sci. 2025 Jul 28. doi: 10.1007/s10620-025-09261.
    PubMed     Abstract available
    
    
    
67. KARIM A, Memon S, Irshad NUN, Jaslok F, et al
    Critical Appraisal of Cystic Duct Stenting Versus Other Treatment Modalities for the Management of Acute Cholecystitis in Patients with Decompensated Cirrhosis.
    Dig Dis Sci. 2025 Jul 28. doi: 10.1007/s10620-025-09284.
    PubMed    
    
    
    
68. BHATT N, Imran F, Irshad NUN, Bai P, et al
    Clinical Insights on "Severe Hypoxia and Immune?Related Features Predict Prognosis in Patients with Hepatocellular Carcinoma".
    Dig Dis Sci. 2025 Jul 28. doi: 10.1007/s10620-025-09259.
    PubMed    
    
    
    
69. WENTWORTH BJ, Geng CX, Novicoff WM, Siragy HM, et al
    Adrenal Dysfunction in Outpatients with Decompensated Cirrhosis: Impairment in the Hypothalamic-Pituitary-Adrenal Axis.
    Dig Dis Sci. 2025 Jul 26. doi: 10.1007/s10620-025-09237.
    PubMed     Abstract available
    
    
    
70. AMEYAW PA, Boateng S, Issaka Y, Ackah ES, et al
    Outcomes of Acute Pancreatitis in Lean Versus Non-lean Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Patients: A Nationwide Analysis.
    Dig Dis Sci. 2025 Jul 26. doi: 10.1007/s10620-025-09245.
    PubMed     Abstract available
    
    
    
71. XU J, Zhang C, Lv J, Zhao R, et al
    Spontaneous Hepatic Artery Thrombosis with Hepatic Infarction: Successful Interventional Thrombolysis.
    Dig Dis Sci. 2025 Jul 25. doi: 10.1007/s10620-025-09248.
    PubMed    
    
    
    
72. CHEN W, Zhang X, Chi M, Zheng Q, et al
    Intratumoral Microbe Correlated with Expression of DNA Methylation Genes in Hepatocellular Carcinoma.
    Dig Dis Sci. 2025 Jul 25. doi: 10.1007/s10620-025-09157.
    PubMed     Abstract available
    
    
    
73. LIU H, Zhou W, Li C, Shen H, et al
    AHCTF1 Functions as an Oncogenic Factor and Promotes Tumor Progression in Hepatocellular Carcinoma.
    Dig Dis Sci. 2025 Jul 24. doi: 10.1007/s10620-025-09187.
    PubMed     Abstract available
    
    
    
74. IRSHAD NUN, Wajahat K, Kumari V, Bhatt N, et al
    Clinical Insights on "Predicting Esophageal Varices and Varices Needing Treatment in Compensated Advanced Chronic Liver Disease".
    Dig Dis Sci. 2025 Jul 24. doi: 10.1007/s10620-025-09274.
    PubMed    
    
    
    
75. YEN YH, Kuo FY, Eng HL, Liu YW, et al
    Tumor Size Does Not Affect Survival Outcomes of Patients Undergoing Resection for a Single Hepatocellular Carcinoma Without Microscopic Vascular Invasion in the Modern Era of Antiviral Therapy.
    Dig Dis Sci. 2025 Jul 24. doi: 10.1007/s10620-025-09254.
    PubMed     Abstract available
    
    
    
76. PASTA A, Pieri G, Giannini EG
    Autoimmune Hepatitis-Associated Hepatocellular Carcinoma: Clarifying the Evidence-A Reply.
    Dig Dis Sci. 2025 Jul 24. doi: 10.1007/s10620-025-09243.
    PubMed    
    
    
    
77. FAISAL MS, Harris KB, Faisal MS, Ashraf T, et al
    Cystic Duct Stenting Versus Other Treatment Modalities for the Management of Acute Cholecystitis in Patients with Decompensated Cirrhosis.
    Dig Dis Sci. 2025 Jul 10. doi: 10.1007/s10620-025-09163.
    PubMed     Abstract available
    
    
    
78. THANDASSERY RB, John N, Mashal FA, Timmermann CJ, et al
    Predicting Esophageal Varices and Varices Needing Treatment in Compensated Advanced Chronic Liver Disease.
    Dig Dis Sci. 2025 Jul 3. doi: 10.1007/s10620-025-09193.
    PubMed     Abstract available
    
    
    
79. HE M, Wang X, Xu X, Wang X, et al
    Roles of Hypoxia and Mitochondrial Energy Metabolism Related Genes in Predicting the Prognosis of Liver Hepatocellular Carcinoma.
    Dig Dis Sci. 2025 Jul 1. doi: 10.1007/s10620-025-09185.
    PubMed     Abstract available
    
    
    
80. ZHU D, Chen X
    Identification and Confirmation of Shared Etiology and Hub Biomarkers in Nonalcoholic Steatohepatitis and Crohn's Disease.
    Dig Dis Sci. 2025 Jul 1. doi: 10.1007/s10620-025-09190.
    PubMed     Abstract available
    
    
    
81. LO CH, Verma R, Amin R, Manne V, et al
    Rural-Urban Disparities in Mortality Related to Alcohol-Associated Liver Disease by Race/Ethnicity in the United States From 1999 to 2022.
    Dig Dis Sci. 2025;70:2303-2310.
    PubMed     Abstract available
    
    
    
82. HU Y, Zhou M, Liu D, Gong J, et al
    Risk Factors for Glue Extrusion Bleeding After Endoscopic Injection of Cyanoacrylate Glue for Gastric Varices: A Retrospective Study of 269 Patients.
    Dig Dis Sci. 2025;70:2444-2453.
    PubMed     Abstract available
    
    
    June 2025
83. OVIEDO BUSTOS L, Frattini M, Comanzo CG, Vera MC, et al
    Unraveling the Role of Leukotriene A4 Hydrolase in Hepatocellular Carcinoma: Implications for Targeted Therapy and Tumor Progression.
    Dig Dis Sci. 2025 Jun 28. doi: 10.1007/s10620-025-09162.
    PubMed     Abstract available
    
    
    
84. KADRI R, Ma M, Montano-Loza A, Moctezuma-Velazquez C, et al
    Performance of RETREAT Score in a Liver Transplant Program That Follows Total Tumor Volume Criteria.
    Dig Dis Sci. 2025 Jun 27. doi: 10.1007/s10620-025-09191.
    PubMed     Abstract available
    
    
    
85. AHMAD B, Arshad A, Muhammad N
    Comment on "Characteristics and Outcomes of Hepatocellular Carcinoma in Patients with Autoimmune Hepatitis".
    Dig Dis Sci. 2025 Jun 26. doi: 10.1007/s10620-025-09201.
    PubMed    
    
    
    
86. MARIUSSI M, Gallo Ruelas M, Costa de Oliveira Lima L, Furtado Leite F, et al
    Selective Internal Radiation Therapy Combined with Immune Checkpoint Inhibitors in the Treatment of Hepatocellular Carcinoma: A Systematic Review and Single-Arm Meta-Analysis.
    Dig Dis Sci. 2025 Jun 26. doi: 10.1007/s10620-025-09139.
    PubMed     Abstract available
    
    
    
87. PAREDES-MARIN A, Napoli J, Sivakumar V, Near C, et al
    Identifying Environmental Factors Associated with Significant Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease/Steatohepatitis.
    Dig Dis Sci. 2025 Jun 19. doi: 10.1007/s10620-025-09138.
    PubMed     Abstract available
    
    
    
88. LU L, Ma Y, Lu Y, Luo Z, et al
    PDHA1 Orchestrates Hepatocellular Carcinoma Progression Through LINC00607-Mediated Regulation of Cuproptosis and Immune Evasion.
    Dig Dis Sci. 2025 Jun 18. doi: 10.1007/s10620-025-09137.
    PubMed     Abstract available
    
    
    
89. HUANG Y, Zeng J, Liu T, Xu Q, et al
    E2F2/MUC1 Enhances Cell Stemness of Hepatocellular Carcinoma by Regulating the Notch Signaling Pathway.
    Dig Dis Sci. 2025 Jun 18. doi: 10.1007/s10620-025-09148.
    PubMed     Abstract available
    
    
    
90. LU Y, Li X, Zhao K, Qiu P, et al
    Seven Hypoxia and Immune-Related Features Predict Prognosis in Patients with Hepatocellular Carcinoma.
    Dig Dis Sci. 2025 Jun 18. doi: 10.1007/s10620-025-09152.
    PubMed     Abstract available
    
    
    
91. LI R, Lee S, Caldwell PC, Tsavaris KL, et al
    In-Hospital Outcomes of Patients with Hepatorenal Syndrome Who Underwent Transjugular Intrahepatic Portosystemic Shunt Procedure.
    Dig Dis Sci. 2025 Jun 11. doi: 10.1007/s10620-025-09130.
    PubMed     Abstract available
    
    
    
92. BELCHER JM
    Predicting the Use of Dialysis for Acute Kidney Injury in Patients with Cirrhosis-Does Diagnosis Matter?
    Dig Dis Sci. 2025 Jun 5. doi: 10.1007/s10620-025-09143.
    PubMed    
    
    
    
93. LIU X, Xia Y, Zhu J, Liu X, et al
    Long-Term Outcomes of Carvedilol Plus Endoscopic Variceal Ligation in Secondary Prophylaxis of Variceal Bleeding.
    Dig Dis Sci. 2025;70:2138-2146.
    PubMed     Abstract available
    
    
    
94. MA C, Goldberg DS
    Impact of the Underutilization of Vibration-Controlled Transient Elastography in MASLD Patients Without Insurance Coverage.
    Dig Dis Sci. 2025;70:2007-2015.
    PubMed     Abstract available
    
    
    
95. ATTANASI ML, Gregoski MJ, Rockey DC
    Racial Differences in Liver Fibrosis Burden.
    Dig Dis Sci. 2025;70:2178-2185.
    PubMed     Abstract available
    
    
    May 2025
96. OWAIS M, Kumar D, Anjum A, Kumar J, et al
    Clinical Insights on Characteristics and Outcomes of Hepatocellular Carcinoma in Patients with Autoimmune Hepatitis.
    Dig Dis Sci. 2025 May 31. doi: 10.1007/s10620-025-09124.
    PubMed    
    
    
    
97. DE CARVALHO MS, Ferreira CN
    Hot TIPS-Success of Transjugular Intrahepatic Portosystemic Shunt in Patients with Cavernous Transformation of the Portal Vein.
    Dig Dis Sci. 2025 May 20. doi: 10.1007/s10620-025-09087.
    PubMed    
    
    
    
98. JALIL S, Mumtaz K
    Heart of the Matter: Uncovering the Link Between Heart Failure and Cirrhosis Mortality.
    Dig Dis Sci. 2025 May 19. doi: 10.1007/s10620-025-09092.
    PubMed    
    
    
    
99. PASTA A, Pieri G, Plaz Torres MC, Missale G, et al
    Characteristics and Outcomes of Hepatocellular Carcinoma in Patients with Autoimmune Hepatitis.
    Dig Dis Sci. 2025 May 3. doi: 10.1007/s10620-025-09064.
    PubMed     Abstract available
    
    
    
100. LIU Y, Mo W, Sun W, Chen J, et al
     NFAT2 Induces Tumor Cell Proliferation and Metastasis by Acting as a Transcriptional Co-activator of the TGF-beta1/SMAD Signaling Pathway and Inducing the Epithelial-Mesenchymal Transition in Liver Cancer.
     Dig Dis Sci. 2025;70:1799-1812.
     PubMed     Abstract available
     
     
     
101. CHEN F, Zhou Z, Fu J, Gao C, et al
     Selenomethionine Alleviates Alcohol-Induced Liver Injury by Inhibiting Ferroptosis.
     Dig Dis Sci. 2025;70:1779-1787.
     PubMed     Abstract available
     
     
     
102. CAPINHA F, Carvalhana S, Cortez-Pinto H
     Role of Alcohol in Steatotic Liver Disease: Impact on Patients with Cardiometabolic Risk Factors.
     Dig Dis Sci. 2025;70:1746-1756.
     PubMed     Abstract available
     
     
     April 2025
103. LAI SW
     Calcium Channel Blocker and Hepatocellular Carcinoma Risk.
     Dig Dis Sci. 2025 Apr 27. doi: 10.1007/s10620-025-09080.
     PubMed    
     
     
     
104. HOU F, Yan H, Gao C, Wang R, et al
     Regional Portal Hypertension Related to Pancreatic Cancer Surgery.
     Dig Dis Sci. 2025 Apr 25. doi: 10.1007/s10620-025-09063.
     PubMed    
     
     
     
105. ABUSULIMAN M, Dawod S, Nimri F, Jamali T, et al
     Predictive Factors of Post-ERCP Hepatic Decompensation in Patients with Cirrhosis: A Retrospective Case-Control Study.
     Dig Dis Sci. 2025 Apr 24. doi: 10.1007/s10620-025-09071.
     PubMed     Abstract available
     
     
     
106. RAZZAQ R, Nguyen M, Connelly MA, Baral A, et al
     Liver Transplantation and Metabolic Dysfunction Associated Steatotic Liver Disease Is Associated with Markers of Metabolic Risk and Inflammation.
     Dig Dis Sci. 2025 Apr 24. doi: 10.1007/s10620-025-09072.
     PubMed     Abstract available
     
     
     
107. LU R, Abuduhailili X, Li Y, Wang S, et al
     Integrated Analysis of PSMB8 Expression and Its Potential Roles in Hepatocellular Carcinoma.
     Dig Dis Sci. 2025 Apr 22. doi: 10.1007/s10620-025-09040.
     PubMed     Abstract available
     
     
     
108. ABREU ES, Reginato PH, Pitanga JFJ, Borges PN, et al
     Obeticholic Acid vs Fibrates as Second-Line Therapy for Primary Biliary Cholangitis: Systematic Review and Meta-Analysis.
     Dig Dis Sci. 2025 Apr 19. doi: 10.1007/s10620-025-09044.
     PubMed     Abstract available
     
     
     
109. YANG W, Li D, Zhang J
     Transcatheter Arterial Chemoembolization in a Patient with Complete Situs Inversus Totalis and Massive Primary Hepatocellular Carcinoma.
     Dig Dis Sci. 2025 Apr 16. doi: 10.1007/s10620-025-09035.
     PubMed    
     
     
     
110. AZIZ S, Hamid A, Shaikh A, Mansoor R, et al
     Unveiling Disparities in Heart Failure and Cirrhosis Related Mortality: CDC WONDER 1999 to 2020.
     Dig Dis Sci. 2025 Apr 10. doi: 10.1007/s10620-025-08970.
     PubMed     Abstract available
     
     
     
111. ZHU T, Wan X
     Hepatic Subcapsular Hematoma Induced by Metastatic Tumors.
     Dig Dis Sci. 2025 Apr 9. doi: 10.1007/s10620-025-09036.
     PubMed    
     
     
     
112. TAO T, Lv L, Chen J, He Y, et al
     Identification of Crosstalk Genes Between Primary Sjogren's Syndrome and Primary Biliary Cirrhosis by Transcriptome Analysis.
     Dig Dis Sci. 2025 Apr 8. doi: 10.1007/s10620-025-08917.
     PubMed     Abstract available
     
     
     
113. SINGAL AK
     Hepatocellular Carcinoma in Acute Porphyria: Incidence and Risk Factors.
     Dig Dis Sci. 2025 Apr 2. doi: 10.1007/s10620-025-09003.
     PubMed    
     
     
     
114. LEUNG CW, Tapper EB
     Food Insecurity Is Increasing and Is More Common Among Persons with Chronic Liver Disease.
     Dig Dis Sci. 2025;70:1360-1367.
     PubMed     Abstract available
     
     
     
115. SOGBE M, Hummer B, Stine JG, Lizaola-Mayo B, et al
     Advanced Liver Fibrosis Impairs Cardiorespiratory Fitness in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease.
     Dig Dis Sci. 2025;70:1530-1539.
     PubMed     Abstract available
     
     
     
116. KEHAR M, Huerta-Saenz L, Strain J, Kawesa S, et al
     Challenges in Promoting Physical Activity for Managing MASLD in Canadian Children: Insights and Barriers.
     Dig Dis Sci. 2025;70:1368-1374.
     PubMed     Abstract available
     
     
     March 2025
117. TSENG HT, Liu PH, Hsu CY, Huang YH, et al
     Differential Prognostic Impact of Tumor Burden Score on Hepatocellular Carcinoma Patients with Variable Physical Performance Status.
     Dig Dis Sci. 2025 Mar 28. doi: 10.1007/s10620-025-08971.
     PubMed     Abstract available
     
     
     
118. FAN T, Zhu X, Ma X, Yin B, et al
     Severe Hyperhomocysteinemia, an Unusual Case of Liver Cirrhosis.
     Dig Dis Sci. 2025 Mar 28. doi: 10.1007/s10620-025-09006.
     PubMed    
     
     
     
119. LISSING M, Harper P, Wahlin S
     Hepatocellular Carcinoma in Acute Porphyria: Incidence and Risk Factors.
     Dig Dis Sci. 2025 Mar 26. doi: 10.1007/s10620-025-08959.
     PubMed    
     
     
     
120. TRUONG E, Alnimer L, Gornbein JA, Yang JD, et al
     Agile 3+ and 4 Scores Accurately Predict Major Adverse Liver Outcomes, Liver Transplant, Progression of MELD Score, the Development of Hepatocellular Carcinoma, and Death in NAFLD.
     Dig Dis Sci. 2025 Mar 24. doi: 10.1007/s10620-025-08850.
     PubMed     Abstract available
     
     
     
121. CHO HJ, Lee E, Kim SS, Cheong JY, et al
     Impact of Antihypertensive and Lipid-Lowering Agents on Hepatocellular Carcinoma Risk in Patients with Fatty Liver Disease and Diabetes.
     Dig Dis Sci. 2025 Mar 19. doi: 10.1007/s10620-025-08935.
     PubMed     Abstract available
     
     
     
122. TSUJI Y, Namisaki T, Takaya H, Nishimura N, et al
     Risk Factors for Intrahepatic Distant Recurrence After Radiofrequency Ablation for Hepatocellular Carcinoma.
     Dig Dis Sci. 2025 Mar 12. doi: 10.1007/s10620-025-08884.
     PubMed     Abstract available
     
     
     
123. CHEN JW, Chen PF, Li J, Duan XH, et al
     Transjugular Intrahepatic Portosystemic Shunt for Preventing Rebleeding of Esophageal Varices in Patients with Portal Cavernous Transformation.
     Dig Dis Sci. 2025 Mar 3. doi: 10.1007/s10620-025-08955.
     PubMed     Abstract available
     
     
     
124. SACHDEVA S, Vaithiyam V, Ahuja A, Reddy RT, et al
     Spontaneous Hepatoduodenal Fistula Due to Ruptured Amoebic Liver Abscess.
     Dig Dis Sci. 2025 Mar 1. doi: 10.1007/s10620-025-08924.
     PubMed    
     
     
     
125. WAIDYARATNE G, Jalil S, Liu A, Liyanarachchi S, et al
     Utility of Advanced Age as a Predictor of Outcomes in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunt.
     Dig Dis Sci. 2025 Mar 1. doi: 10.1007/s10620-025-08940.
     PubMed     Abstract available
     
     
     
126. JAGDISH B, Murone J, Venkat D
     Implementation of Alcohol Use Disorder Training Curriculum Improves Perceived Confidence in Treating Alcohol-Related Liver Disorder Amongst Gastroenterology Fellows.
     Dig Dis Sci. 2025;70:1000-1007.
     PubMed     Abstract available
     
     
     
127. CHIEN SC, Chiu HC, Chiu YC, Wang RH, et al
     Clinical Relevancies of Sarcopenic Obesity in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease (MASLD).
     Dig Dis Sci. 2025;70:1190-1200.
     PubMed     Abstract available
     
     
     
128. ZHANG J, Yang Z, Liu X, Yang X, et al
     New Insights into the Pathogenesis of Alcoholic Liver Disease Based on Global Research.
     Dig Dis Sci. 2025;70:903-918.
     PubMed     Abstract available
     
     
     
129. PIETRI O, Chicaud M, Andreani T, Chretien Y, et al
     Unexplained Chronically Elevated Aminotransferases: Liver Biopsy Gives Major Information with Therapeutic Implication in One Patient Out of Seven.
     Dig Dis Sci. 2025;70:1178-1189.
     PubMed     Abstract available
     
     
     February 2025
130. KUMAR S, Biswas S, Agarwal S, Sheikh S, et al
     Next-Generation Sequencing Identifies Novel Germline Mutations in Patients with Budd-Chiari Syndrome-Associated Hepatocellular Carcinoma.
     Dig Dis Sci. 2025 Feb 28. doi: 10.1007/s10620-025-08942.
     PubMed     Abstract available
     
     
     
131. PAK K, Sachar R, Saab S
     Projected Mitigation of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B in the Gray Zone and the Immune-Tolerant Phase in the United States.
     Dig Dis Sci. 2025 Feb 20. doi: 10.1007/s10620-025-08909.
     PubMed     Abstract available
     
     
     
132. LOEFFLER J, Hassan M, Qaqish F, Dimachkie R, et al
     Predictors of Renal Replacement Therapy Requirement in Cirrhotic Patients with Acute Kidney Injury.
     Dig Dis Sci. 2025 Feb 15. doi: 10.1007/s10620-025-08881.
     PubMed     Abstract available
     
     
     
133. HOLMAN A, Solano Q, Firn J, Tapper E, et al
     Clinical Ethics Consultations in Cirrhosis Care.
     Dig Dis Sci. 2025 Feb 8. doi: 10.1007/s10620-025-08866.
     PubMed     Abstract available
     
     
     
134. LI Y, Ma X, Cui S, Jiang G, et al
     Association Between Serum Uric Acid and Non-alcoholic Fatty Liver Disease in Non-obese Young Population: A Prospective Cohort Study.
     Dig Dis Sci. 2025;70:825-834.
     PubMed     Abstract available
     
     
     
135. CHO EEL, Law M, Yu Z, Yong JN, et al
     Artificial Intelligence and Machine Learning Predicting Transarterial Chemoembolization Outcomes: A Systematic Review.
     Dig Dis Sci. 2025;70:533-542.
     PubMed     Abstract available
     
     
     
136. MALANDRIS K, Korakas E, Sarakapina A, Kalopitas G, et al
     Accuracy of Controlled Attenuation Parameter for Liver Steatosis in High-Risk Patients for MASLD Using MRI-Proton Density Fat Fraction as Reference Standard.
     Dig Dis Sci. 2025;70:814-824.
     PubMed     Abstract available
     
     
     
137. COMAN D, Bilodeau M, Vincent C, Brochiero E, et al
     Integration of Non-invasive Screening for Cystic Fibrosis Related Liver Disease in the Regular Follow-Up for Cystic Fibrosis.
     Dig Dis Sci. 2025;70:526-532.
     PubMed     Abstract available
     
     
     
138. SINGH V, De A, Aggrawal R, Singh A, et al
     Safety and Efficacy of Dapagliflozin in Recurrent Ascites: A Pilot Study.
     Dig Dis Sci. 2025;70:835-842.
     PubMed     Abstract available
     
     
     January 2025
139. BISWAS S, Lo GH, Mehta S, Elhence A, et al
     Abbreviated Duration of Vasoactive Agents Has Similar Outcomes as Standard Duration of Therapy in Patients with Liver Cirrhosis and Variceal Bleeding: An Individual Patient Data Meta-Analysis.
     Dig Dis Sci. 2025 Jan 27. doi: 10.1007/s10620-025-08851.
     PubMed     Abstract available
     
     
     
140. SHIN IS, Moon JH, Lee YN, Park JW, et al
     Re-intervention Utility After Endoscopic Ultrasound-Guided Hepaticogastrostomy Using a Partially Covered Stent with Anchoring Flange.
     Dig Dis Sci. 2025 Jan 27. doi: 10.1007/s10620-025-08852.
     PubMed     Abstract available
     
     
     
141. GALLACHER J, Tavabie OD
     Use of Physical Restraints for Patients with Hepatic Encephalopathy - Why We Should Restrain Our Enthusiasm.
     Dig Dis Sci. 2025 Jan 13. doi: 10.1007/s10620-024-08830.
     PubMed    
     
     
     
142. NJEI B, Mezzacappa C, John BV, Serper M, et al
     Mortality, Hepatic Decompensation, and Cardiovascular Outcomes in Lean vs. Non-lean MASLD Cirrhosis: A Veterans Affairs Cohort Study.
     Dig Dis Sci. 2025 Jan 8. doi: 10.1007/s10620-024-08764.
     PubMed     Abstract available
     
     
     
143. GU J, Cao Z, Niu G, Ying J, et al
     Clinical Significance of Acyl-CoA Dehydrogenase Short Chain and Its Anti-tumor Role in Hepatocellular Carcinoma by Inhibiting Canonical Wnt/beta-Catenin Pathway.
     Dig Dis Sci. 2025 Jan 2. doi: 10.1007/s10620-024-08813.
     PubMed     Abstract available
     
     
     
144. SANG H, Lim J, Kim HI
     Association of Comorbidity Duration with the Occurrence and Prognosis of Steatotic Liver Disease.
     Dig Dis Sci. 2025;70:386-398.
     PubMed     Abstract available
     
     
     
145. BOLLINGER B, Cotter R, Deng Y, Ilagan-Ying Y, et al
     Presence of Mood and/or Anxiety Disorders Does Not Affect Success of Weight Management Therapies in Metabolic Dysfunction-Associated Steatotic Liver Disease.
     Dig Dis Sci. 2025;70:378-385.
     PubMed     Abstract available
     
     
     
146. CELAJ S, Estevez J, Novelli P, Orons P, et al
     Challenges and Opportunities in the Adoption of p-TIPS for Acute Variceal Bleeding: Insights from a US Tertiary Center.
     Dig Dis Sci. 2025;70:399-405.
     PubMed     Abstract available
     
     
     
147. MILLER KC, Geyer B, Alexopoulos AS, Moylan CA, et al
     Disparities in Metabolic Dysfunction-Associated Steatotic Liver Disease Prevalence, Diagnosis, Treatment, and Outcomes: A Narrative Review.
     Dig Dis Sci. 2025;70:154-167.
     PubMed     Abstract available
     
     
     December 2024
148. YAKOVCHENKO V, Chang MF, Hernaez R, Awad JA, et al
     Access to Evaluation for Liver Transplantation in the Veterans Health Administration.
     Dig Dis Sci. 2024 Dec 11. doi: 10.1007/s10620-024-08717.
     PubMed     Abstract available
     
     
     
149. ZOU H, Zhou XL, Liu W
     Hepatic Echinococcosis with Intrapulmonary Metastases.
     Dig Dis Sci. 2024 Dec 2. doi: 10.1007/s10620-024-08768.
     PubMed    
     
     
     
150. CUMPIAN NA, Choi G, Saab S
     Review of Current and Upcoming Second-Line Treatments for Primary Biliary Cholangitis.
     Dig Dis Sci. 2024 Dec 2. doi: 10.1007/s10620-024-08742.
     PubMed     Abstract available
     
     
     
151. LIN Y, Ye H, Chen Y, Zhang R, et al
     Integrative Analyses of Genes of Pediatric Non-alcoholic Fatty Liver Disease Associated with Energy Metabolism.
     Dig Dis Sci. 2024;69:4373-4391.
     PubMed     Abstract available
     
     
     November 2024
152. LOYOLA-VELEZ AJ, John BV
     SGLT2 Inhibitors in Cirrhosis: A Promising Therapeutic Avenue with Potential Risks.
     Dig Dis Sci. 2024 Nov 24. doi: 10.1007/s10620-024-08703.
     PubMed    
     
     
     
153. ALI YO, Goble SR, Leventhal TM
     Disparities and Outcomes of Physical Restraint Use in Hepatic Encephalopathy: A National Inpatient Assessment.
     Dig Dis Sci. 2024 Nov 24. doi: 10.1007/s10620-024-08758.
     PubMed     Abstract available
     
     
     
154. XIAO Y, Shi M, Xiao J, Xie X, et al
     Dynamic Profiles of Internal m7G Methylation on mRNAs in the Progression from HBV Infection to Hepatocellular Carcinoma.
     Dig Dis Sci. 2024 Nov 18. doi: 10.1007/s10620-024-08736.
     PubMed     Abstract available
     
     
     
155. TANG S, He L, Huang T, Zeng Y, et al
     Hepatic Amyloidosis Without Hepatomegaly.
     Dig Dis Sci. 2024 Nov 18. doi: 10.1007/s10620-024-08731.
     PubMed    
     
     
     
156. VERMA M, Chan M, Toroghi S, Gallagher M, et al
     Multimedia-Based Education Led to Improvement in Disease Knowledge Among Patients with Cirrhosis.
     Dig Dis Sci. 2024 Nov 7. doi: 10.1007/s10620-024-08704.
     PubMed     Abstract available
     
     
     
157. GOYAL T, Song MW, Suresh D, Jasty VSJ, et al
     Serial Liver Stiffness Measurement and Fibrosis-4 Scores in Metabolic Dysfunction-Associated Steatotic Liver Disease.
     Dig Dis Sci. 2024;69:4250-4258.
     PubMed     Abstract available
     
     
     
158. JASTY VSJ, Urias E, Le Ashley Tiong K, Aboona MB, et al
     Prognostic Accuracy of Transient Elastography-Based Predictors in Diabetes and Obesity: A Multicenter International Cohort Study.
     Dig Dis Sci. 2024;69:4240-4249.
     PubMed     Abstract available
     
     
     October 2024
159. LIU ZW, Song T, Wang ZH, Sun LL, et al
     Predicting Portal Pressure Gradient in Patients with Decompensated Cirrhosis: A Non-invasive Deep Learning Model.
     Dig Dis Sci. 2024 Oct 28. doi: 10.1007/s10620-024-08701.
     PubMed     Abstract available
     
     
     
160. SHI Y, Gu H, Yuan X, Qian L, et al
     A Case of Multisite Gastric Hepatoid Adenocarcinoma Mimicking Gastric Stromal Tumors.
     Dig Dis Sci. 2024 Oct 24. doi: 10.1007/s10620-024-08680.
     PubMed    
     
     
     
161. SINGAL AK, Reddy RK, Gudiwada MC, Jasti JJ, et al
     Hepatocellular Carcinoma in Acute Hepatic Porphyria: A Meta-Analysis of Observational Studies.
     Dig Dis Sci. 2024 Oct 22. doi: 10.1007/s10620-024-08661.
     PubMed     Abstract available
     
     
     
162. KAWADA T
     Screening Ability of Non-invasive Markers for Detecting Hepatic Fibrosis.
     Dig Dis Sci. 2024 Oct 5. doi: 10.1007/s10620-024-08668.
     PubMed    
     
     
     
163. JINDAL A, Kumar G, Sharma MK, Vashishtha C, et al
     Derivation of Splenic Stiffness in Subjects with Normal Liver Stiffness and No Vascular Liver Disease Using Transient Elastography with a Spleen-Dedicated Module: A Large Cross Sectional Study.
     Dig Dis Sci. 2024;69:3942-3951.
     PubMed     Abstract available
     
     
     
164. KUMARI K, Pahuja SK, Kumar S
     A Comprehensive Examination of ChatGPT's Contribution to the Healthcare Sector and Hepatology.
     Dig Dis Sci. 2024 Oct 1. doi: 10.1007/s10620-024-08659.
     PubMed     Abstract available
     
     
     September 2024
165. OHNO A, Fujimori N, Kaku T, Shimokawa Y, et al
     Feasibility of Endoscopic Ultrasound-Guided Hepaticogastrostomy for Malignant Hilar Biliary Obstruction.
     Dig Dis Sci. 2024 Sep 29. doi: 10.1007/s10620-024-08652.
     PubMed     Abstract available
     
     
     
166. REBILLARD E, De Abreu N, Buchard B, Muti L, et al
     AFP-DIAM Score to Predict Survival in Patients with Hepatocellular Carcinoma Before TACE: A French Multicenter Study.
     Dig Dis Sci. 2024 Sep 25. doi: 10.1007/s10620-024-08639.
     PubMed     Abstract available
     
     
     
167. PATEL KM, Zhang J, Marsden J, Bays C, et al
     Missed and Delayed Diagnoses of Chronic Liver Disease in Primary Care Patients with Cirrhosis.
     Dig Dis Sci. 2024 Sep 20. doi: 10.1007/s10620-024-08601.
     PubMed     Abstract available
     
     
     
168. RULE JA, Ajayi F, James LP, Tujios SR, et al
     Differentiating Ischemic Hepatitis from Acetaminophen Overdose in Acute Liver Failure: Role of Acetaminophen Adducts-Ischemic Hepatitis vs Acetaminophen Overdose.
     Dig Dis Sci. 2024 Sep 2. doi: 10.1007/s10620-024-08602.
     PubMed     Abstract available
     
     
     
169. SOLANO QP, Chen X, Parikh ND, Tapper EB, et al
     Racial and Ethnic Disparities in Outcomes After the Development of Ascites: A National Cohort Study.
     Dig Dis Sci. 2024;69:3214-3219.
     PubMed     Abstract available
     
     
     
170. FU CE, Teng M, Tung D, Ramadoss V, et al
     Sex and Race-Ethnic Disparities in Metabolic Dysfunction-Associated Steatotic Liver Disease: An Analysis of 40,166 Individuals.
     Dig Dis Sci. 2024;69:3195-3205.
     PubMed     Abstract available
     
     
     August 2024
171. DIAZ PM, Saly DL, Horick N, Petrosyan R, et al
     Prognosis of Transplant-Ineligible Patients with Cirrhosis and Acute Kidney Injury Who Initiate Renal Replacement Therapy.
     Dig Dis Sci. 2024 Aug 31. doi: 10.1007/s10620-024-08623.
     PubMed     Abstract available
     
     
     
172. HU Y, Zhou M, Liu D, Gong J, et al
     Risk Factors for Rebleeding After Endoscopic Injection of Cyanoacrylate Glue for Gastric Varices: A Systematic Review and Meta-Analysis.
     Dig Dis Sci. 2024;69:2890-2903.
     PubMed     Abstract available
     
     
     
173. AGGARWAL N, Agarwal A, Alarouri H, Dwarakanathan V, et al
     Patients with Celiac Disease Have High Prevalence of Fatty Liver and Metabolic Syndrome.
     Dig Dis Sci. 2024;69:3029-3042.
     PubMed     Abstract available
     
     
     July 2024
174. IFRAH A, Fromer R, Gayner AH, Yeung HM, et al
     Discharge Outcomes of Hospitalized Patients with New Onset Decompensated Cirrhosis.
     Dig Dis Sci. 2024 Jul 31. doi: 10.1007/s10620-024-08574.
     PubMed     Abstract available
     
     
     
175. LEE DU, Bhowmick K, Althwanay A, Sandlow S, et al
     Etiology-Specific Effects of Impaired Functional Status on Liver Transplant Outcomes.
     Dig Dis Sci. 2024 Jul 16. doi: 10.1007/s10620-024-08522.
     PubMed     Abstract available
     
     
     
176. YAKUBU I, Flynn S, Khan H, Nguyen M, et al
     Burden of Portal Hypertension Complications Is Greater in Liver Transplant Wait-Listed Registrants with End-Stage Liver Disease and Type 2 Diabetes.
     Dig Dis Sci. 2024 Jul 10. doi: 10.1007/s10620-024-08499.
     PubMed     Abstract available
     
     
     
177. EDELSON JC, Rockey DC
     Safety of Endoscopy in Cirrhosis.
     Dig Dis Sci. 2024 Jul 8. doi: 10.1007/s10620-024-08539.
     PubMed     Abstract available
     
     
     
178. GUAN Y, Gan Y, An J
     Clinical Characteristics and Prognosis of Early-Onset Hepatocellular Carcinoma: A Retrospective Cohort Study Based on Population Data.
     Dig Dis Sci. 2024 Jul 4. doi: 10.1007/s10620-024-08549.
     PubMed     Abstract available
     
     
     
179. STERN C, Ngo A, Villela-Nogueira C, Thabut D, et al
     A Simple and Reliable 2D-Shear Wave Elastography and UltraSound Coefficient Attenuation Parameter Technique in Chronic Liver Diseases.
     Dig Dis Sci. 2024;69:2648-2654.
     PubMed     Abstract available
     
     
     June 2024
180. BROWN C, Hernandez R, Ford T, Aksan N, et al
     Inadequate Dietary Education and Poor Adherence to a High Protein, Low Sodium Diet in Cirrhosis: Mixed Methods Approach.
     Dig Dis Sci. 2024 Jun 28. doi: 10.1007/s10620-024-08526.
     PubMed     Abstract available
     
     
     
181. YANG JO, Chittajallu P, Benhammou JN, Patel A, et al
     Validation of a Machine Learning Algorithm, EVendo, for Predicting Esophageal Varices in Hepatocellular Carcinoma.
     Dig Dis Sci. 2024 Jun 19. doi: 10.1007/s10620-024-08449.
     PubMed     Abstract available
     
     
     
182. HANSEN S, Gilroy R, Lindsay I, Doty JR, et al
     A Meta-Analysis of Cumulative Incidence of Hepatocellular Carcinoma After the Fontan Operation.
     Dig Dis Sci. 2024 Jun 13. doi: 10.1007/s10620-024-08470.
     PubMed     Abstract available
     
     
     
183. FULLER SR, Schreiner AD
     Hepatic Fibrosis Risk Assessment in Primary Care: Opportunities and Challenges.
     Dig Dis Sci. 2024 Jun 6. doi: 10.1007/s10620-024-08498.
     PubMed    
     
     
     
184. SHIH HW, Lai Y, Hung HC, Lee JC, et al
     Liver Resection Criteria for Patients with Hepatocellular Carcinoma and Multiple Tumors Based on Total Tumor Volume.
     Dig Dis Sci. 2024 Jun 1. doi: 10.1007/s10620-024-08500.
     PubMed     Abstract available
     
     
     
185. JINDAL A, Singh H, Kumar G, Arora V, et al
     Early Versus Standard Initiation of Terlipressin for Acute Kidney Injury in ACLF: A Randomized Controlled Trial (eTerli Study).
     Dig Dis Sci. 2024;69:2204-2214.
     PubMed     Abstract available
     
     
     May 2024
186. ZHOU Y, Zhang Q, Kong Y, Guo X, et al
     Retraction Note: Insulin-Like Growth Factor Binding Protein-Related Protein 1 Activates Primary Hepatic Stellate Cells via Autophagy Regulated by the PI3K/Akt/mTOR Signaling Pathway.
     Dig Dis Sci. 2024 May 29. doi: 10.1007/s10620-024-08506.
     PubMed    
     
     
     
187. KOCH DG, Rockey DC, Litwin SS, Tedford RJ, et al
     H2FPEF Scores Are Increased in Patients with NASH Cirrhosis and Are Associated with Post-liver Transplant Heart Failure.
     Dig Dis Sci. 2024 May 23. doi: 10.1007/s10620-024-08438.
     PubMed     Abstract available
     
     
     
188. UFERE NN
     Increasing Healthcare System Empathy for Patients with Advanced Liver Disease: My Top 10 Lessons in Palliative Hepatology.
     Dig Dis Sci. 2024 May 4. doi: 10.1007/s10620-024-08406.
     PubMed    
     
     
     
189. PEMMASANI G, Tremaine W, Karagozian R, John S, et al
     Impact of Cirrhosis Etiology on the Risk for Venous Thromboembolism.
     Dig Dis Sci. 2024 May 3. doi: 10.1007/s10620-024-08440.
     PubMed     Abstract available
     
     
     
190. THRIFT AP, Nguyen Wenker TH, Godwin K, Balakrishnan M, et al
     An Electronic Health Record Model for Predicting Risk of Hepatic Fibrosis in Primary Care Patients.
     Dig Dis Sci. 2024 May 3. doi: 10.1007/s10620-024-08437.
     PubMed     Abstract available
     
     
     
191. IM KH, Saeed WK, Kim EB, Lee AH, et al
     Deletion of Mixed Lineage Kinase Domain Like Pseudokinase Aggravates Chronic Alcohol-Induced Liver Injury via Increasing Apoptosis.
     Dig Dis Sci. 2024;69:1701-1713.
     PubMed     Abstract available
     
     
     
192. DONG Y, Xu H, Zhang Z, Zhou Z, et al
     A Novel Nomogram for Predicting Early Rebleeding After Endoscopic Treatment of Esophagogastric Variceal Hemorrhage.
     Dig Dis Sci. 2024;69:1852-1862.
     PubMed     Abstract available
     
     
     April 2024
193. TAN C, Zeng X, Guo X, Mo M, et al
     A Novel lncRNA lncRNA-4045 Promotes the Progression of Hepatocellular Carcinoma by Affecting the Expression of AKR1B10.
     Dig Dis Sci. 2024 Apr 25. doi: 10.1007/s10620-024-08383.
     PubMed     Abstract available
     
     
     
194. MARCANTEI C, Couret A, King J, Mazeaud S, et al
     Effects of Exercise Training on Muscle Mass and Physical Function in Patients with Hepatocellular Carcinoma After Diagnosis: A Systematic Review.
     Dig Dis Sci. 2024 Apr 25. doi: 10.1007/s10620-024-08441.
     PubMed     Abstract available
     
     
     
195. HSIEH HC, Chang WP, Huang PJ, Wang CH, et al
     Effectiveness of Exercise Interventions on Body Composition, Exercise Capacity, Fatigue, and Quality of Life in Patients with Liver Cirrhosis: A Meta-Analysis of Randomized Controlled Trials.
     Dig Dis Sci. 2024 Apr 24. doi: 10.1007/s10620-024-08447.
     PubMed     Abstract available
     
     
     
196. HORBAL SR, Belancourt PX, Zhang P, Holcombe SA, et al
     Independent Associations of Aortic Calcification with Cirrhosis and Liver Related Mortality in Veterans with Chronic Liver Disease.
     Dig Dis Sci. 2024 Apr 23. doi: 10.1007/s10620-024-08450.
     PubMed     Abstract available
     
     
     
197. CHANG ML, Le PH, Chen WT, Chen TD, et al
     Hepatic and Extrahepatic Characteristics of Autoimmune Hepatitis: A 23-year Hospital-Based Cohort Study.
     Dig Dis Sci. 2024 Apr 23. doi: 10.1007/s10620-024-08439.
     PubMed     Abstract available
     
     
     
198. ZHANG X, Wang W, Mo S, Sun X, et al
     DEAD-Box Helicase 17 circRNA (circDDX17) Reduces Sorafenib Resistance and Tumorigenesis in Hepatocellular Carcinoma.
     Dig Dis Sci. 2024 Apr 23. doi: 10.1007/s10620-024-08401.
     PubMed     Abstract available
     
     
     
199. MOON AM, Swier RM, Lane LM, Barritt AS 4th, et al
     Statewide Survey of Primary Care and Subspecialty Providers on Hepatocellular Carcinoma Risk-Stratification and Surveillance Practices.
     Dig Dis Sci. 2024 Apr 23. doi: 10.1007/s10620-024-08442.
     PubMed     Abstract available
     
     
     
200. MANNING ME, Fricker Z
     Cardiopulmonary Resuscitation Outcomes and Trainee Perception of Code Status Discussions in Patients with Cirrhosis.
     Dig Dis Sci. 2024 Apr 23. doi: 10.1007/s10620-024-08443.
     PubMed     Abstract available
     
     
     
201. TWOHIG PA, Peeraphatdit TB, Samson K, Schissel M, et al
     A Prospective Multimodal Education Intervention for Providers Does Not Increase Hepatic Encephalopathy Treatment Rates.
     Dig Dis Sci. 2024 Apr 23. doi: 10.1007/s10620-024-08445.
     PubMed     Abstract available
     
     
     
202. WEBER S, Unger K, Alunni-Fabbroni M, Hirner-Eppeneder H, et al
     Metabolomic Analysis of Human Cirrhosis and Hepatocellular Carcinoma: A Pilot Study.
     Dig Dis Sci. 2024 Apr 23. doi: 10.1007/s10620-024-08446.
     PubMed     Abstract available
     
     
     
203. MCCURDY H, Nobbe A, Scott D, Patton H, et al
     Organizational and Implementation Factors Associated with Cirrhosis Care in the Veterans Health Administration.
     Dig Dis Sci. 2024 Apr 14. doi: 10.1007/s10620-024-08409.
     PubMed     Abstract available
     
     
     
204. PEARLMAN BL
     Direct-Acting Antiviral Therapy for Patients with Chronic Hepatitis C Infection and Decompensated Cirrhosis.
     Dig Dis Sci. 2024 Apr 5. doi: 10.1007/s10620-024-08393.
     PubMed     Abstract available
     
     
     
205. KHAMSEH ME, Malek M, Jahangiri S, Nobarani S, et al
     Insulin Resistance/Sensitivity Measures as Screening Indicators of Metabolic-Associated Fatty Liver Disease and Liver Fibrosis.
     Dig Dis Sci. 2024;69:1430-1443.
     PubMed     Abstract available
     
     
     
206. POP A, Halegoua-DeMarzio D, Barnhart H, Kleiner D, et al
     Amiodarone and Dronedarone Causes Liver Injury with Distinctly Different Clinical Presentations.
     Dig Dis Sci. 2024;69:1479-1487.
     PubMed     Abstract available
     
     
     
207. WILLIAMS EE, Mladenovic A, Ranginani D, Weber R, et al
     Role of Spleen Stiffness Measurement in the Evaluation of Metabolic Dysfunction-Associated Steatotic Liver Disease.
     Dig Dis Sci. 2024;69:1444-1453.
     PubMed     Abstract available
     
     
     
208. BEHARI J
     Spleen Stiffness Measurement in Metabolic Dysfunction-Associated Steatotic Liver Disease-Value Added or Work in Progress?
     Dig Dis Sci. 2024;69:1093-1095.
     PubMed    
     
     
     March 2024
209. WANG H, Liu X, Xie Y, Qin X, et al
     A Case of Immunoglobulin Light Chain Hepatic Amyloidosis with Abdominal Hematoma.
     Dig Dis Sci. 2024 Mar 30. doi: 10.1007/s10620-024-08342.
     PubMed    
     
     
     
210. JAFRI F, Saad S, Riaz H, Saleem F, et al
     Lack of Diversity in Transplant Hepatology Fellowship Program Directorship.
     Dig Dis Sci. 2024 Mar 23. doi: 10.1007/s10620-024-08388.
     PubMed     Abstract available
     
     
     
211. ARSHAD T, Vainer D, Khan H, Baral A, et al
     Development of Clinical Algorithm Utilizing Vibration-Controlled Transient Elastography to Detect Advanced Hepatic Fibrosis in Liver Transplant Recipients.
     Dig Dis Sci. 2024 Mar 18. doi: 10.1007/s10620-024-08366.
     PubMed     Abstract available
     
     
     
212. KAHN-BOESEL O, Mitchell H, Li L, Zhu E, et al
     Hospital-Level Care at Home for Patients with Cirrhosis.
     Dig Dis Sci. 2024 Mar 11. doi: 10.1007/s10620-024-08361.
     PubMed     Abstract available
     
     
     
213. PETROSYAN R, Endres P, Ufere NN, St Hillien SA, et al
     Healthcare Resource Utilization and Goals of Care Discussions in Patients with Cirrhosis and Acute Kidney Injury.
     Dig Dis Sci. 2024 Mar 7. doi: 10.1007/s10620-024-08317.
     PubMed     Abstract available
     
     
     
214. PATEL AA, Walling A, Bansal A
     A New Look at Goals-of-Care Discussions in Patients with Cirrhosis and Acute Kidney Injury.
     Dig Dis Sci. 2024 Mar 7. doi: 10.1007/s10620-024-08300.
     PubMed    
     
     
     
215. REN J, Yao X, Yang M, Cheng S, et al
     Kinesin Family Member-18A (KIF18A) Promotes Cell Proliferation and Metastasis in Hepatocellular Carcinoma.
     Dig Dis Sci. 2024 Mar 6. doi: 10.1007/s10620-024-08321.
     PubMed     Abstract available
     
     
     
216. KIM RG, Patel S, Satre DD, Shumway M, et al
     Telehepatology Satisfaction Is Associated with Ethnicity: The Real-World Experience of a Vulnerable Population with Fatty Liver Disease.
     Dig Dis Sci. 2024;69:732-742.
     PubMed     Abstract available
     
     
     
217. JAROENLAPNOPPARAT A, Mettler SK, Guillen H, Chayanupatkul M, et al
     Changes in the Prevalence, Incidence, and Disability-Adjusted Life Years of Non-alcoholic Fatty Liver Disease in the United States Between 1990 and 2019.
     Dig Dis Sci. 2024;69:702-712.
     PubMed     Abstract available
     
     
     
218. VASSILOPOULOS A, Kalligeros M, Vassilopoulos S, Shehadeh F, et al
     Prevalence of Steatotic Liver Disease Among US Adults with Rheumatoid Arthritis.
     Dig Dis Sci. 2024;69:989-1003.
     PubMed     Abstract available
     
     
     
219. SADLIK G, Anderson RC, Lei X, Cen SY, et al
     Pseudocirrhosis: A Case Series with Clinical and Radiographic Correlation and Review of the Literature.
     Dig Dis Sci. 2024;69:1004-1014.
     PubMed     Abstract available
     
     
     February 2024
220. KALAITZAKIS ZE, Giahnakis E, Koutroubakis IE, Mouzas IA, et al
     Bariatric Nutritional Intervention in Obese Patients with Compensated Liver Cirrhosis: A Four-Year Prospective Study.
     Dig Dis Sci. 2024 Feb 27. doi: 10.1007/s10620-023-08223.
     PubMed     Abstract available
     
     
     
221. ZHAO X, Guo X, Zhao Y, Yu Y, et al
     Gastrointestinal Bleeding Was Diagnosed as Small Intestinal Metastasis of Hepatocellular Carcinoma by Double-Balloon Enteroscopy.
     Dig Dis Sci. 2024 Feb 21. doi: 10.1007/s10620-024-08339.
     PubMed    
     
     
     
222. YE N, Shi X, Gao J, Dong R, et al
     Exosomes from Intrahepatic Cholestasis of Pregnancy Induce Cell Apoptosis Through the miRNA-6891-5p/YWHAE Pathway.
     Dig Dis Sci. 2024 Feb 15. doi: 10.1007/s10620-023-08265.
     PubMed     Abstract available
     
     
     
223. GU Y, Chen G, Ning X
     Homeobox Protein BarH-like 1 Promotes Gastric Cancer Progression by Activating Coiled-Coil Domain-Containing Protein 178.
     Dig Dis Sci. 2024 Feb 15. doi: 10.1007/s10620-024-08312.
     PubMed     Abstract available
     
     
     
224. ARE VS, Gromski MA, Akisik F, Vilar-Gomez E, et al
     Primary Sclerosing Cholangitis Limited to Intrahepatic Bile Ducts Has Distinctly Better Prognosis.
     Dig Dis Sci. 2024 Feb 12. doi: 10.1007/s10620-023-08260.
     PubMed     Abstract available
     
     
     
225. MUKUND A, Aravind A, Jindal A, Tevethia HV, et al
     Predictors and Outcomes of Post-transjugular Intrahepatic Portosystemic Shunt Liver Failure in Patients with Cirrhosis.
     Dig Dis Sci. 2024 Feb 10. doi: 10.1007/s10620-023-08256.
     PubMed     Abstract available
     
     
     
226. YILMAZ L, Bulut A, Aytekin A, Baskonus I, et al
     A Novel Technique for the Management of Persistent Biliary Fistulas Developing After Liver Hydatid Cyst Surgeries: Drain Clamping Technique.
     Dig Dis Sci. 2024 Feb 10. doi: 10.1007/s10620-024-08284.
     PubMed     Abstract available
     
     
     
227. LI R, Sarin S
     Disparity Among African Americans in Transjugular Intrahepatic Portosystemic Shunt Procedure: A National Inpatient Sample Analysis from 2015 to 2020.
     Dig Dis Sci. 2024 Feb 6. doi: 10.1007/s10620-024-08273.
     PubMed     Abstract available
     
     
     
228. BATSAIKHAN B, Dai CY
     Treatment of Hepatocellular Carcinoma in the Elderly: Slash or Burn?
     Dig Dis Sci. 2024 Feb 1. doi: 10.1007/s10620-023-08247.
     PubMed    
     
     
     
229. KIM JI, Lee J, Choi GH, Lee MW, et al
     Comparison of Surgical Resection and Radiofrequency Ablation in Elderly Patients with Hepatocellular Carcinoma.
     Dig Dis Sci. 2024 Feb 1. doi: 10.1007/s10620-023-08245.
     PubMed     Abstract available
     
     
     
230. ZEREM E, Denjagic Basic M, Kurtcehajic A, Zerem D, et al
     Indications for the Use of Endoscopic Ultrasound-Guided Liver Biopsy in Patients with Liver Fibrosis.
     Dig Dis Sci. 2024;69:643-644.
     PubMed    
     
     
     
231. ASHKTORAB H, Challa SR, Singh G, Nanduri S, et al
     Gastrointestinal Manifestations and Their Association with Neurologic and Sleep Problems in Long COVID-19 Minority Patients: A Prospective Follow-Up Study.
     Dig Dis Sci. 2024;69:562-569.
     PubMed     Abstract available
     
     
     
232. WAJSBROT NB, Leite NC, Franca PHC, Cardoso CRL, et al
     Parental History of Type 2 Diabetes Mellitus and PNPLA3 Polymorphism Increase the Risk of Severe Stages of Nonalcoholic Fatty Liver Disease.
     Dig Dis Sci. 2024;69:634-642.
     PubMed     Abstract available
     
     
     
233. FIGUEROA G, Castaneda S, McLean H, Dukandar J, et al
     Low Health Literacy, Lack of Knowledge, and Self-Control Hinder Healthy Lifestyles in Diverse Patients with Steatotic Liver Disease.
     Dig Dis Sci. 2024;69:384-398.
     PubMed     Abstract available
     
     
     
234. BEHARI J, Bradley A, Townsend K, Becich MJ, et al
     Limitations of Noninvasive Tests-Based Population-Level Risk Stratification Strategy for Nonalcoholic Fatty Liver Disease.
     Dig Dis Sci. 2024;69:370-383.
     PubMed     Abstract available
     
     
     January 2024
235. HUANG FD, Zhong YP, Sun GY, Xu QJ, et al
     Fanconi Anemia Complementary Group A (FANCA) Facilitates the Occurrence and Progression of Liver Hepatocellular Carcinoma.
     Dig Dis Sci. 2024 Jan 28. doi: 10.1007/s10620-024-08282.
     PubMed     Abstract available
     
     
     
236. ASADA S, Namisaki T, Kaji K, Takaya H, et al
     VWF/ADAMTS13 Ratio as a Potential Predictive Biomarker for Acute Kidney Injury Onset in Cirrhosis.
     Dig Dis Sci. 2024 Jan 20. doi: 10.1007/s10620-023-08257.
     PubMed     Abstract available
     
     
     
237. BOWMAN CA, Bichoupan K, Posner S, Schonfeld E, et al
     A Prospective Open-Label Dose-Response Study to Correct Vitamin D Deficiency in Cirrhosis.
     Dig Dis Sci. 2024 Jan 13. doi: 10.1007/s10620-023-08224.
     PubMed     Abstract available
     
     
     
238. TSAI SY, O'Leary JG
     Optimizing Outcomes in Patients with Ascites Complicating Cirrhosis-Maximizing the Hour of Power.
     Dig Dis Sci. 2024 Jan 13. doi: 10.1007/s10620-023-08255.
     PubMed    
     
     
     
239. BADAL J, Badal B, Nawras M, Lee-Smith W, et al
     Diagnostic Paracentesis Within 1 Day Is Associated With Reduced Mortality and Length of Hospital Stay in Patients with Cirrhosis and Ascites.
     Dig Dis Sci. 2024 Jan 13. doi: 10.1007/s10620-023-08249.
     PubMed     Abstract available
     
     
     
240. LIN W, Zhao Z, Du W, Ni Z, et al
     Interferon-Gamma-Inducible Protein 16 Inhibits Hepatocellular Carcinoma via Interferon Regulatory Factor 3 on Chemosensitivity.
     Dig Dis Sci. 2024 Jan 3. doi: 10.1007/s10620-023-08175.
     PubMed     Abstract available
     
     
     
241. BLOOM PP, Che Z, Hyde A, Johnson E, et al
     Development and Evaluation of a Patient Cirrhosis Knowledge Assessment.
     Dig Dis Sci. 2024 Jan 3. doi: 10.1007/s10620-023-08238.
     PubMed     Abstract available
     
     
     December 2023
242. JAMES M, Alazawi W
     Non-invasive Tests of Fibrosis: Does One Size Fit All?
     Dig Dis Sci. 2023;68:4285-4286.
     PubMed    
     
     
     
243. ARORA U, Goyal RM, Teh KKJ, Pei Y, et al
     Poor Performance of Non-invasive Tests for Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: A Multicentric Asian Study.
     Dig Dis Sci. 2023;68:4485-4498.
     PubMed     Abstract available
     
     
     November 2023
244. SUN Y, Lu M, Feldman R, Saul M, et al
     Positive Predictive Value of Cirrhosis and Chronic Pancreatitis Diagnoses in Individuals with Alcohol Use Disorder: A Single-Center Study.
     Dig Dis Sci. 2023 Nov 29. doi: 10.1007/s10620-023-08183.
     PubMed     Abstract available
     
     
     
245. SOHAL A, Kohli I, Chaudhry H, Singh I, et al
     Vaccine-Preventable Illness Leads to Adverse Outcomes in Liver Transplant Recipients.
     Dig Dis Sci. 2023 Nov 29. doi: 10.1007/s10620-023-08202.
     PubMed     Abstract available
     
     
     
246. WONG ZY, Koh JH, Muthiah M, Koh B, et al
     Proton Pump Inhibitors Increases Longitudinal Risk of Mortality, Decompensation, and Infection in Cirrhosis: A Meta-Analysis.
     Dig Dis Sci. 2023 Nov 15. doi: 10.1007/s10620-023-08150.
     PubMed     Abstract available
     
     
     
247. LOW EXS, Wang YP, Lu CL
     Risks of Proton Pump Inhibitors in Patients with Cirrhosis: Please Peruse the Indications.
     Dig Dis Sci. 2023 Nov 15. doi: 10.1007/s10620-023-08153.
     PubMed     Abstract available
     
     
     
248. TIAN X, Wang Y, Yuan M, Zheng W, et al
     Heme Oxygenase-1-Modified BMMSCs Activate AMPK-Nrf2-FTH1 to Reduce Severe Steatotic Liver Ischemia-Reperfusion Injury.
     Dig Dis Sci. 2023;68:4196-4211.
     PubMed     Abstract available
     
     
     
249. WU YT, Li QZ, Zhao XK, Mu M, et al
     Anlotinib Attenuates Liver Fibrosis by Regulating the Transforming Growth Factor beta1/Smad3 Signaling Pathway.
     Dig Dis Sci. 2023;68:4186-4195.
     PubMed     Abstract available
     
     
     October 2023
250. JINDAL A, Sharma MK, Vijayaraghavan R, Sm S, et al
     Severity of Acute Portal Hypertension Determines the Clinical Outcomes in Severe Alcoholic Hepatitis.
     Dig Dis Sci. 2023 Oct 31. doi: 10.1007/s10620-023-08144.
     PubMed     Abstract available
     
     
     
251. GONZALEZ HC, Trudeau S
     COVID-19 + Cirrhosis = Excess Hospital Confinement, Excess Casualties.
     Dig Dis Sci. 2023 Oct 21. doi: 10.1007/s10620-023-08106.
     PubMed    
     
     
     
252. TWOHIG PA, Scholten K, Schissel M, Brittan K, et al
     Mortality Increased Among Hospitalized Patients with Cirrhosis Before and Following Different Waves of the COVID-19 Pandemic.
     Dig Dis Sci. 2023 Oct 21. doi: 10.1007/s10620-023-08105.
     PubMed     Abstract available
     
     
     
253. BANGARU S, Sundaresh R, Lee A, Prause N, et al
     Predictive Algorithm for Hepatic Steatosis Detection Using Elastography Data in the Veterans Affairs Electronic Health Records.
     Dig Dis Sci. 2023 Oct 21. doi: 10.1007/s10620-023-08043.
     PubMed     Abstract available
     
     
     
254. KILANI Y, Kamal SAF, Vikash F, Vikash S, et al
     Correction to: Racial Disparities in Liver Transplantation for Hepatocellular Carcinoma in the United States: An Update.
     Dig Dis Sci. 2023 Oct 13. doi: 10.1007/s10620-023-08131.
     PubMed    
     
     
     
255. WANG L, Zhang Y, Li J, Guo S, et al
     A Nomogram of Magnetic Resonance Imaging for Preoperative Assessment of Microvascular Invasion and Prognosis of Hepatocellular Carcinoma.
     Dig Dis Sci. 2023 Oct 4. doi: 10.1007/s10620-023-08022.
     PubMed     Abstract available
     
     
     
256. DAKROUB A, Anouti A, Cotter TG, Lee WM, et al
     Mortality and Morbidity Among Adult Liver Retransplant Recipients.
     Dig Dis Sci. 2023;68:4039-4049.
     PubMed     Abstract available
     
     
     
257. KAUR P, Verma N, Valsan A, Garg P, et al
     Prevalence, Risk Factors, and Impact of Bacterial or Fungal Infections in Acute Liver Failure Patients from India.
     Dig Dis Sci. 2023;68:4022-4038.
     PubMed     Abstract available
     
     
     
258. SMAYRA K, Miangul S, Yap N, Shi A, et al
     Technical Success, Sample Adequacy, and Complications of Pediatric Transjugular Liver Biopsy: A Systematic Review and Meta-Analysis.
     Dig Dis Sci. 2023;68:3846-3856.
     PubMed     Abstract available
     
     
     
259. LI R, Li M, Bidulescu A, Fly AD, et al
     Diets with Higher Anti-inflammatory Potential Associated with Lower Risk of Development of Nonalcoholic Fatty Liver Disease and Early-Stage of Fibrosis Among US Adults.
     Dig Dis Sci. 2023;68:4009-4021.
     PubMed     Abstract available
     
     
     September 2023
260. GOBLE S, Akambase J, Prieto J, Balderramo D, et al
     MBOAT7 rs641738 Variant Is Not Associated with an Increased Risk of Hepatocellular Carcinoma in a Latin American Cohort.
     Dig Dis Sci. 2023 Sep 8. doi: 10.1007/s10620-023-08104.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum